Skip to content

Communication During Hospitalization About Resuscitation Trial

Communication During Hospitalization About Resuscitation Trial

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02984124
Acronym
CHART
Enrollment
182
Registered
2016-12-06
Start date
2016-12-01
Completion date
2025-12-01
Last updated
2026-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease, Severe Functional Impairment, Severe Life-limiting Cirrhosis, Severe Life-limiting COPD, Severe Life-limiting Heart Failure, Severe Life-limiting Malignancy

Brief summary

This multicenter RCT of 200 hospitalized patients and their family members evaluates an "informed assent" approach to discussing cardiopulmonary resuscitation, compared to usual care, in older seriously ill hospitalized patients with severe life-limiting illness or severe functional impairment.

Detailed description

Increasing evidence suggests that high quality palliative care in older patients improves quality of care, patient and family satisfaction, and costs of care. However, while some specific palliative care interventions have been investigated, exactly how we should provide this care remains unclear. One important component of high quality provider-patient communication is discussing cardiopulmonary resuscitation (CPR) within the context of the patient's values and goals of care. Unfortunately, these conversations are often rushed, focused only on the procedure rather than the patient's goals and values, and CPR is often offered as if a choice on a menu. Elderly hospitalized patients are unlikely to have made decisions about CPR prior to hospitalization, and these discussions often leave patients and families feeling burdened, stressed, and concerned. Outcomes after in-hospital CPR in chronically ill older patients continue to be very poor, despite decades of efforts toward improvement. The investigators aim to change the paradigm of CPR discussions with older adults unlikely to benefit from CPR. This study is a randomized controlled trial comparing an innovative "informed assent" approach to discussing CPR versus usual care with attention control for older hospitalized adults with life-limiting illness or severe functional impairment, enrolling patients and family members at three different study sites. Informed assent includes: 1) eliciting values and goals, 2) explaining CPR in the context of illness, and 3) a caring statement that the patient should not receive CPR if values include avoiding burdensome therapies unlikely to provide benefit. Thus, the provider can elicit values, convey information, and state an assessment, while allowing the patient or family to disagree. The investigators hypothesize that informed assent will improve quality of and satisfaction with communication about CPR; reduce the burden of potentially harmful CPR discussions, including reduced patient and family symptoms of depression and anxiety; and reduce intensity of care and health care utilization. The intervention builds on prior work investigating CPR outcomes in older adults and performing pilot studies of the informed assent intervention in both inpatients and outpatients.

Interventions

BEHAVIORALInformed Assent Discussion

Participants randomized to the intervention arm will participate in a discussion about CPR with a study doctor that follows these steps: 1. Patient's values and preferences for therapies and outcomes elicited from patient and family; overall therapeutic goals formulated 2. Description of CPR and dying process provided 3. Personalized explanation provided about probable lack of achieving any reasonable therapeutic goal with CPR (i.e. why s/he is a poor candidate for CPR due to underlying illness) 4. Patient and family informed that due to severe underlying illness and high likelihood that CPR will be burdensome/harmful and will not provide benefit, CPR will not be offered unless they disagree (except in rare circumstance where overall therapeutic goals from step 1 are to preserve life regardless of quality of that life) Assessment of patient's and family's understanding of issues discussed; patients may actively disagree and request CPR be performed, but CPR not explicitly offered

Participants who are randomized to the usual care arm will receive a friendly visit in the hospital from research personnel to ask if they have any questions or concerns. Follow up assessments and time windows will be explained. Importance of their participation in the study will be emphasized.

Sponsors

University of Vermont
Lead SponsorOTHER
University of Washington
CollaboratorOTHER
Medical University of South Carolina
CollaboratorOTHER
University of North Carolina, Chapel Hill
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. \>65 years old 2. English speaking 3. Must have one or more of the following: 1. Chronic life-limiting illness with median survival \<2 years defined as: 1) metastatic cancer or inoperable lung cancer; 2) COPD requiring oxygen; 3) New York Heart Association Class III or IV heart failure, 4) Child's Class C cirrhosis or MELD score of \>20, 5) End-stage renal disease (must be on dialysis and ≥ 75 years old), 6) Advanced pulmonary fibrosis/interstitial lung disease, 7) Advanced pulmonary hypertension 2. Severe functional impairment defined as dependence with \>4 activities of daily living (ADLs) on Katz Index of Independence in ADLs.

Exclusion criteria

1. Has already definitively chosen DNR status 2. Unable to provide informed consent 3. Refused consent 4. Currently listed on a transplant list (awaiting transplant) 5. Inappropriate for study enrollment per clinician 6. Known to have a left ventricular assist device (LVAD) 7. Research team unavailable 8. Patient discharged from hospital prior to enrollment

Design outcomes

Primary

MeasureTime frameDescription
Quality of Communication Questionnaire (QOCQ), slightly modified to focus on communication about cardiopulmonary resuscitationStudy day 5 +/- 1 or hospital discharge, whichever is earlierPatient-Assessed Quality of Communication about CPR

Secondary

MeasureTime frameDescription
Quality of Communication Questionnaire (QOCQ), slightly modified to focus on communication about cardiopulmonary resuscitationStudy day 5 +/- 1 or hospital discharge, whichever is earlierFamily-Assessed Quality of Communication about CPR
5-question communication domain of the CANHELP Questionnaire, slightly modified to focus on communication about cardiopulmonary resuscitationStudy day 5 +/- 1 or hospital discharge, whichever is earlierPatient-Assessed Satisfaction with Communication about CPR
Hospital Anxiety and Depression Survey (HADS)Study day 5 +/- 1 or hospital discharge (whichever is earlier), 3 months, and 6 monthsPatient Depressive and Anxiety Symptoms
Do-Not-Resuscitate Orders (yes/no)Study day 5 +/- 1 or hospital discharge (whichever is earlier), 3 months, and 6 months
Time to Do-Not-Resuscitate OrdersTo 6 months post-randomization
Admission to the intensive care unit (ICU) 9yes/no)Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
ICU length of stay (days)Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
Tracheostomy placement (yes/no)Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
Gastrostomy tube placement (yes/no)Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
Receipt of mechanical ventilation (yes/no)Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
Receipt of renal replacement therapy (yes/no)Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
Receipt of cardiopulmonary resuscitation (yes/no)Measured at the time hospital discharge, which will likely occur at an average of 6 days after admission, but will be assessed for up to 6 months.
Cost of health care after initial hospitalization3 months and 6 months post-randomizationRepeat hospital admissions, ICU admissions, nursing home says, hospice care stays, and use of home health care will be assessed, and if they occurred, duration will be recorded. A standardized value (costs, not charges) will be applied to these measures to determine overall cost.
Mortality (dead or alive)To 6 months post-randomization

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRenee Stapleton, MD PhD

University of Vermont

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 30, 2026